Table 2 Prevalence of Metabolic Syndrome factors in all overweight, obese, and extremely obese adolescents according to BMI and by gender

Total

AbdC >90^thP ^(1)**

55.0%

30.4% ^a

54.5% ^b

87.0% ^c

TG ≥150 mg/dL^(1)*

18.5%

15.9% ^ab

13.0% ^a

29.6% ^b

HDLc <40 mg/dL^(1)NS

35.5%

29.0% ^a

37.7%^a

40.7%^a

SBP-DBP ≥130/85^(1)**

21.0%

10.1% ^a

18.2% ^a

38.9% ^b

Glycemia ≥100 mg/dL^(2)NS

2.0%

2.9% ^a

1.3% ^a

1.9% ^a

(n = 174)

(n = 55)

(n = 71)

(n = 48)

Female

AbdC >90^thP ^(2)**

67.0%

41.9% ^a

65.0% ^a

96.6% ^b

TG ≥150 mg/dL^(2)NS

19.0%

12.9% ^a

15.0% ^a

31.0% ^a

HDLc <40 mg/dL^(1)*

41.0%

22.6% ^a

47.5% ^ab

51.7% ^b

SBP-DBP ≥130/85^(2)**

21.0%

9.7% ^a

15.0% ^a

41.4% ^b

Glycemia ≥100 mg/dL^(2)NS

3.0%

3.2% ^a

2.5% ^a

3.4% ^a

(n = 147)

(n = 40)

(n = 58)

(n = 49)

Male

AbdC >90^thP^(1)**

43.0%

21.1% ^a

43.2% ^a

76.0% ^b

TG ≥150 mg/dL^(2)NS

18.0%

18.4% ^a

10.8% ^a

28.0% ^a

HDLc <40 mg/dL^(1)NS

30.0%

34.2% ^a

27.0% ^a

28.0% ^a

SBP-DBP ≥130/85^(2)*

21.0%

10.5% ^a

21.6% ^ab

36.0% ^b

Glycemia ≥100 mg/dL^(2)NS

1.0%

2.6% ^a

0.0% ^a

0.0% ^a